Lung cancer is one of the most common and deadly types of cancer. CyberKnife offers a non-invasive treatment option that uses stereotactic radiosurgery to deliver high doses of radiation directly to the tumor. This is particularly useful for patients who cannot undergo surgery due to their health condition or the tumor's location. CyberKnife's precision minimizes exposure to healthy lung tissue and nearby vital structures, reducing side effects and allowing for more comfortable and effective treatment.

Mediastinal tumors, located in the central area of the chest between the lungs, can be benign or malignant. CyberKnife allows for a highly focused approach to treating these tumors, avoiding the need for invasive surgery and minimizing risk to nearby vital organs such as the heart and major blood vessels.

Tumors affecting the chest wall, including sarcomas and metastatic carcinomas, can be difficult to surgically remove. CyberKnife allows these tumors to be treated with a high dose of precise radiation, reducing the chance of recurrence and preserving the structural and functional integrity of the chest.

Lung metastases originate from cancers located in other parts of the body. CyberKnife provides a precise therapeutic option that can treat multiple metastatic lesions simultaneously, offering a less invasive alternative to surgery with minimal disruption to the patient's daily life.

CyberKnife is particularly useful in treating metastases affecting the spinal cord and spine, providing local tumor control without the need for invasive surgery. This helps relieve pain and prevent or treat spinal cord compression, significantly improving the patient's quality of life.